Seeking Alpha

Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with ...

The study evaluated the efficacy and safety of the investigational immunotherapy combination of TECVAYLI ® plus DARZALEX FASPRO ® versus DARZALEX FASPRO ® and dexamethasone with either pomalidomide or ...
MedPage Today

AMA Recommends USMLE Step 3 Transition to Pass/Fail

Should the U.S. Medical Licensing Examination (USMLE) Step 3 be scored? Members of the American Medical Association (AMA) don't think so, and passed policy to that effect during the annual House of ...
VentureBeat

Doron Therapeutics Announces First Patients Dosed in Phase 3 Study of MOTYS (PTP-001) for the Treatment of Osteoarthritis of the Knee

Doron Therapeutics, a clinical-stage biotechnology company developing novel biologics for musculoskeletal diseases, today announced that the initial patients have been dosed in its Phase 3 clinical ...
Nasdaq

J&J : Phase 3 Study Of Icotrokinra Shows Significant Skin Clearance & Safety In Plaque Psoriasis

(RTTNews) - Johnson & Johnson (JNJ) announced new icotrokinra (JNJ-2113) data from its Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis (PsO) seeking to ...